Spreadsheet: 060a201a-5b21-4867-a367-60f4c26dd8bb
Sheet: Sheet1

Autoantigens: | Unnamed: 1 | Unnamed: 2 | Unnamed: 3 | Unnamed: 4 | Unnamed: 5
 |  |  |  | Length of ALL DISORDERED Regions >=20
ExPASy | Protein | SwissProt | Disease | or longest region if none >= 20 | Length of LDRs (Long Disordered Region) >=40
RSMB_HUMAN | SmB/SmB' | (P14678) | SLE | 190 | 190
SMD1_HUMAN | Sm-D1 | (P62314) | SLE | 39
SMD2_HUMAN | Sm-D2 | (P62316) | SLE | 21,33
SMD3_HUMAN | Sm-D3 | (P62318) | SLE | 23,46 | 46
RU1A_HUMAN | U1 snRNP A | (P09012) | SLE | 131 | 131
RU17_HUMAN | U1 snRNP 70K | ([NAME]) | SLE | 40,48,195 | 40,48,195
RU1C_HUMAN | U1 snRNP C | (P09234) | SLE | 95 | 95
RU2A_HUMAN | U2 snRNP A' | (P09661) | SLE | 36,47 | 47
RU2B_HUMAN | U2 snRNP B" | (P08579) | SLE | 56 | 56
RO52_HUMAN | Ro52K SS-A1 | (P19474) | SLE,SS | 23,51,79 | 51,79
[NAME] | Ro60K SS-A2 | (P10155) | SLE,SS | 23,28
LA_HUMAN | La SS-B | (P05455) | SLE,SS | 22,27,30,40 | 40
H14_HUMAN | Histone H1b | (P10412) | SLE | 51, 107 | 51, 107
H2AC_HUMAN | Histone H2A.1b | (P02261) | SLE | 27,27
H2BA_HUMAN | Histone H2B.1a | (P62807) | SLE | 39 | 39
H31_HUMAN | Histone H3.1 | (P16106) | SLE | 65 | 65
H4_HUMAN | Histone H4 | (P62805) | SLE | 53 | 53
TOP1_HUMAN | DNA topoisomerase I | (P11387) | SScl (retroviral p30gag) | 40,66,80,88 | 39,40,66,80,88
CENA_HUMAN | CENP-A | (P49450) | [NAME], Crest(SScl sub) | 62 | 62
CENB_HUMAN | CENP-B | (P07199) | [NAME], Crest(SScl sub) | 23,32,48,61,87 | 48,61,87
CENC_HUMAN | CENP-C | (Q03188) | SS, SScl, autoantigen | 24,26,26,29,30,31,33,46,49,54,155 | 46,49,54,155
KU86_HUMAN | Ku86 | ([NAME]) | SLE | 17
KU70_HUMAN | Ku70 | (P12956) | SLE, Cterm 190 residues | 26,26,36
ANXB_HUMAN | [NAME] | (P50995) | SLE,SS,RA | 26,30,41,127 | 41127
RP38_HUMAN | RNaseP p38 | (P78345) | SScl, 4/4 sera | 24,35,75 | 75
RP30_HUMAN | RNaseP p30 | (P78346) | SScl, 2/4 sera | 19
RUV1_HUMAN | RuvB-like 1 | (Q9Y265) | PM, [NAME], AH | 20,21,22
CHD3_HUMAN | CHD-3 | ([NAME]) | [NAME] | 20,26,29,38,40,52,71,86,92,94,162 | 40,52,71,86,92,94,162
CHD4_HUMAN | CHD-4 | (Q14839) | [NAME] | 21,24,24,26,27,35,38,39,49,61,71,132,159 | 49,61,71,132,159
RCC1_HUMAN | RCC1 | (P18754) | Ray | 29,30,37,40 | 40
PMC2_HUMAN | PM/Scl-100, PM/Scl-2 | (Q01780) | PM,SScl | 20,21,24,25,26,31,41 | 41
RR45_HUMAN | PM/Scl-75, PM/Scl-1 | (Q06265) | PM,SScl | 39,98 | 98
[NAME] | RRP42 | (Q15024) | PM,SScl | 19
RRP4_HUMAN | RRP4 | (Q13868) | PM,SScl | 26
FBRL_HUMAN | Fibrillarin | (P22087) | SScl, in 8% patients | 28,62 | 62
UBF1_HUMAN | UBF-1 | (P17480) | SScl, Autoantigen NOR-90 | 21,23,24,25,29,82,121 | 82121
PSE3_HUMAN | PA28g | (P61289) | SLE | 21,22
SSNA_HUMAN | [NAME] | (O43805) | SS | 57 | 57
[NAME] | hnRNP A/B | (Q99729) | SLE, RA, MCTD | 21,25,30,65 | 65
ROA2_HUMAN | hnRNP A2 | (P22626) | SLE, RA, MCTD | 26,26,38,39
[NAME] | [NAME] | (Q9Y3S2) | RA, Nucleolar autoantigen 36 | 28,30,
SFR1_HUMAN | ASF-1 SRp30a | (Q07955) | SLE | 33,65 | 65
SFR2_HUMAN | SC35  SRp30b | (Q01130) | SLE | 22,25,130 | 130
SFR3_HUMAN | SRp20 | (P84103) | SLE | 89 | 89
SFR4_HUMAN | SRp75 | (Q08170) | SLE | 29, 339 | 339
SFR5_HUMAN | SRp40 | (Q13243) | SLE | 56, 104 | 56, 104
SFR6_HUMAN | SRp55 | ([NAME]) | SLE | 20,35,183 | 183
YB1_HUMAN | DBP1 | (P67809) | SScl,SLE | 53, 230 | 53, 230
NUMA_HUMAN | NUMA1 | (Q14980) | SS | 29,31,35,37,38,39,39,39,40,56,59,59,64,76,81,83,85,102,109,110,127,131 | 40,56,59,59,64,76,81,83,85,102,109,110,127,131
[NAME] | Eg5Kinesin-likeNUMA-2 | (P52732) | SS, SLE | 23,24,24,25,29,31,38,42,66 | 42,66
PCNA_HUMAN | PCNA (cyclin) | (P12004) | SLE sera contains PCNA | 21
Disease Abbreviation:
SLE  = [NAME]
SS   = Sjogren Syndrome
SScl = Scleroderma (Systemic Sclerosis)
PM   = Polymyositis
[NAME]  = Dermatomyositis
[NAME]  = Raynaud disease,
RA   = Rheumatoid Arthritis
MCTD = Mixed Connective Tissue Disease